Highest-materiality recent filing
American Healthcare REIT closes 13.25M share forward offering for senior housing acquisition
Closed public offering of 13,250,000 shares of common stock on Aug 12, 2026.
Aggregate purchase price $873M for 745 units across CA, MD, NY, VA; deposits $8.73M non-refundable.
American Healthcare REIT Q2 NFFO $0.54, raises FY 2026 guidance; Same-Store NOI +13.2%
GAAP net income $30.6M ($0.16/diluted); NFFO $0.54/diluted for Q2 2026.
American Healthcare REIT CEO Danny Prosky retires; Jeff Hanson named permanent CEO
Danny Prosky retired as CEO/President effective July 21, 2026; continues as director and advisor.
All nine director nominees elected; highest vote for Danny Prosky (156.5M shares), lowest for Mathieu B. Streiff (99.2M for, 58.3M withheld).
American Healthcare REIT declares Q2 2026 dividend of $0.25 per share
Quarterly distribution of $0.25 per share, annualized rate $1.00 per share.
American Healthcare REIT closes additional 2.1M share forward sale from underwriter option exercise
Underwriter exercised option in full on May 26, 2026 to purchase 2.1M additional shares of common stock.
American Healthcare REIT closes public offering of 14M shares on forward basis
Closed offering of 14,000,000 shares of common stock on a forward basis on May 22, 2026.
American Healthcare REIT Q1 NFFO $0.50 (+30% YoY); raises FY2026 guidance
GAAP net income $23.7M ($0.13/diluted share); NFFO $0.50/diluted share, up >30% YoY.
American Healthcare REIT amends credit facility; revolver increased to $800M, matures Apr 2030
Second Amendment to 2024 Credit Agreement executed April 1, 2026; revolving loan capacity raised from $600M to $800M.
American Healthcare REIT finalizes interim CEO pay: $70,667/mo base, ~$4.05M equity grants
Base salary of $70,666.67 per month, effective Feb 4, 2026; target bonus 120% of annualized base, pro-rated for service period.
American Healthcare REIT declares Q1 2026 dividend of $0.25/share
Quarterly distribution of $0.25 per share ($1.00 annualized) for Q1 2026.
American Healthcare REIT enters new ATM equity program for up to $1.75B
New ATM Sales Agreement with 11 agents for up to $1.75B of common stock.
American Healthcare REIT Q4 GAAP net income $10.8M, NFFO $0.46/sh; guides FY2026 NFFO $1.99-$2.05
Q4 GAAP net income $10.8M ($0.06 diluted EPS); full year 2025 net income $69.8M ($0.42 diluted EPS).
CEO Danny Prosky takes medical leave; Chairman Jeffrey Hanson named interim CEO
CEO Danny Prosky on medical leave effective Feb 3, 2026 due to a recent medical event.
American Healthcare REIT declares Q4 2025 dividend of $0.25/share
Quarterly distribution of $0.25 per share, annualized $1.00 per share.
Closed public offering of 8,100,000 shares; underwriter exercised option in full for 1,215,000 additional shares.
American Healthcare REIT closes public offering of 8.1M shares in forward sale
Closed public offering of 8,100,000 shares on November 24, 2025, via forward sale agreement with RBC Capital Markets.
American Healthcare REIT Q3 2025: GAAP EPS $0.33, NFFO $0.44, raises FY guidance
GAAP net income $55.9M ($0.33/share); NFFO $0.44/share.
American Healthcare REIT declares $0.25 Q3 2025 distribution, payable Oct 17
Quarterly distribution of $0.25 per share ($1.00 annualized) declared.
American Healthcare REIT launches $1B ATM equity offering program
New ATM program allows sale of up to $1B in common stock through multiple agents.
American Healthcare REIT Q2 NFFO $0.42; raises FY 2025 guidance, SS NOI growth 13.9%
GAAP net income $9.9M ($0.06 EPS); NFFO $0.42 per diluted share.
American Healthcare REIT shareholders elect all 9 directors, ratify Deloitte & Touche
Nine director nominees elected with 100.7M to 116.7M shares for each; highest withheld votes 16.6M for Brian Flornes.
American Healthcare REIT declares Q2 2025 dividend of $0.25 per share
Quarterly distribution of $0.25 per share, annualized rate of $1.00 per share.
American Healthcare REIT corrects loss from unconsolidated entities to $1.848M (was $0) in Q1 2025
Amendment revises 'Loss from unconsolidated entities' from $0 to $1.848M for Q1 2025 and from $0 to $1.205M for Q1 2024.
American Healthcare REIT Q1 NFFO $0.38; raises FY25 guidance on strong NOI growth
GAAP net loss $6.8M ($0.04/diluted); NFFO $0.38/diluted.
American Healthcare REIT declares Q1 2025 distribution of $0.25 per share
Quarterly distribution of $0.25 per share (annualized $1.00) for the quarter ending March 31, 2025.
AHR Q4 NFFO $0.40/sh; FY25 guidance NFFO $1.56-$1.60; same-store NOI +21.6%
Q4 GAAP net loss $(0.21)/sh; NFFO $0.40/sh. FY24 GAAP net loss $(0.29)/sh; NFFO $1.41/sh.
American Healthcare REIT amends bylaws to let stockholders amend with majority vote
Board approved Second Amended and Restated Bylaws on February 21, 2025, effective immediately.
American Healthcare REIT declares Q4 2024 dividend of $0.25 per share
Quarterly distribution of $0.25 per share, annualized to $1.00 per share.
American Healthcare REIT establishes $500M ATM equity offering program
Up to $500M of common stock may be sold through BofA, Barclays, Citigroup, Morgan Stanley and other agents.
American Healthcare REIT Q3 NFFO $0.36/share; raises FY2024 NFFO guidance to $1.40-$1.43
GAAP net loss $3.1M ($0.03 diluted EPS); NFFO $0.36 per diluted share.
All nine director nominees elected, though Brian Flornes received nearly equal withheld votes (36.9M withheld vs 37.0M for) and Valerie Richardson and Wilbur Smith also had substantial withheld.
Closed public offering of 20,010,000 shares on Sep 20, 2024; underwriters' option exercised in full.
American Healthcare REIT declares Q3 2024 dividend of $0.25 per share
Quarterly distribution of $0.25 per share, annualized rate of $1.00 per share.
American Healthcare REIT Q2 net income $2.9M; raises full-year NFFO and NOI guidance
GAAP net income of $2.9M ($0.01 diluted EPS) vs net loss of $11.9M in Q2 2023.
American Healthcare REIT sets Nov 7, 2024 annual meeting; shareholder deadlines July 10, 2024
Annual meeting scheduled for November 7, 2024, more than 30 days after prior year's anniversary.
American Healthcare REIT declares $0.25 quarterly distribution payable July 19, 2024
Quarterly distribution of $0.25 per share (annualized $1.00) declared for Q2 2024.
American Healthcare REIT releases June 2024 investor presentation (no material new info)
Filed investor presentation for use in meetings with investors as Exhibit 99.1.
American Healthcare REIT Q1 GAAP EPS $(0.04), NFFO $0.30; same-store NOI +13%
GAAP net loss $(0.04)/share; NFFO $0.30/share for Q1 2024.
AHR Board remains neutral on unsolicited mini-tender at $9.07, 34% below market
CMG Partners offers $9.07/share for up to 225,000 Class T and I shares vs. NYSE close $13.79.
GAAP net loss $(0.42) per share Q4, $(1.08) FY2023; NFFO $0.38 Q4, $1.40 FY2023.
Board neutral on Comrit tender offer at $5.23/share; declares Q1 $0.25 dividend
Comrit amended mini-tender to $5.23/share (from $13.15), extended to Mar 31; AHR stock closed at $13.80 on Mar 14.
AHR amends credit facility to $1.15B, repays $721M debt, updates occupancy and acquisition
Credit facility: $600M revolver (matures Feb 2028) and $550M term loan (matures Jan 2027), replacing 2022 facility.
American Healthcare REIT closes NYSE IPO of 64.4M shares at $12.00, nets $717.6M
Closed public offering of 64.4M shares at $12.00/share; net proceeds $717.6M used to reduce outstanding debt.
AHR launches public stock offering; webcast for existing stockholders on Feb 12
On Jan 29, 2024, AHR launched a public offering of common stock in connection with a proposed NYSE listing.
American Healthcare REIT board neutral on Comrit mini-tender at $13.15/share
Comrit offers to buy up to 228,136 Class T and I shares at $13.15/share, equivalent to $3.29 pre-reverse split.
American Healthcare REIT declares $0.25 quarterly distribution
Record date: December 27, 2023 for Class T and Class I stockholders.
American Healthcare REIT publishes Q3 2023 investor update letter
The furnished investor letter contains operational and financial updates for Q3 2023.
Option to purchase remaining 48% membership interest in Trilogy REIT Holdings for $240.5M–$260M cash, depending on closing date, plus possible supplemental payment up to ~$21M.
On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.
On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.
On April 6, 2023, Harold H. Greene, Gerald W. Robinson and J. Grayson Sanders, independent directors of American Healthcare REIT, Inc. (the “Company”), notified the Company of their respective intent to retire from the Company’s Board of Directors effective as of June 14, 2023.
increased the size of our Board to 12 members and appointed Marvin R. O’Quinn and Valerie Richardson to fill the two outstanding vacancies on our Board effective January 10, 2023.
increased the size of our Board to 12 members and appointed Marvin R. O’Quinn and Valerie Richardson to fill the two outstanding vacancies on our Board effective January 10, 2023.
On August 30, 2022, our board of directors, or our Board, increased the size of our Board to ten members and appointed Scott A. Estes to fill the outstanding vacancy on our Board and serve as a director of our company and a member of the audit committee of our Board, or our Audit Committee.
Mathieu B. Streiff informed our board of directors of his intention to transition from his position as Chief Operating Officer to Executive Vice President effective August 1, 2022, and then to retire from that position effective January 1, 2023 .
Mathieu B. Streiff informed our board of directors of his intention to transition from his position as Chief Operating Officer to Executive Vice President effective August 1, 2022, and then to retire from that position effective January 1, 2023 .
our board of directors appointed Gabriel M. Willhite, age 41 , as our Chief Operating Officer effective August 1, 2022.
the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.
the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.
the Company assumed from GAHR III the Offer Letters dated October 1, 2021 for Jeffrey T. Hanson, Danny Prosky, Mathieu B. Streiff and Brian S. Peay.
Max materiality 0.85 · Median 0.60 · Most common event other_material